132 related articles for article (PubMed ID: 38652507)
1. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
Kim NH; Kang JH; Kim HJ
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
[TBL] [Abstract][Full Text] [Related]
2. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
[TBL] [Abstract][Full Text] [Related]
3. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
[TBL] [Abstract][Full Text] [Related]
4. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.
Lu Y; Hu L; Song J; Wan J; Chen H; Yin J
BMC Endocr Disord; 2021 Nov; 21(1):231. PubMed ID: 34794397
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
[TBL] [Abstract][Full Text] [Related]
6. Impact of nonalcoholic fatty liver disease on the risk of gallbladder polyps in lean and non-obese individuals: A cohort study.
Kim NH; Kang JH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2024 Jan; ():. PubMed ID: 38336522
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
[TBL] [Abstract][Full Text] [Related]
8. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.
Ruhl CE; Everhart JE
Am J Gastroenterol; 2013 Jun; 108(6):952-8. PubMed ID: 23545713
[TBL] [Abstract][Full Text] [Related]
9. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.
Tobari M; Hashimoto E; Taniai M; Ikarashi Y; Kodama K; Kogiso T; Tokushige K; Takayoshi N; Hashimoto N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1404-1410. PubMed ID: 30590868
[TBL] [Abstract][Full Text] [Related]
11. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
12. The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Shi Y; Wang Q; Sun Y; Zhao X; Kong Y; Ou X; Jia J; Wu S; You H
J Clin Gastroenterol; 2020 Apr; 54(4):378-387. PubMed ID: 31651571
[TBL] [Abstract][Full Text] [Related]
13. Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.
Chen N; Zhou J; Wang K; Li X; Li Z
BMJ Open Diabetes Res Care; 2023 Feb; 11(1):. PubMed ID: 36792168
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in lean individuals in the United States.
Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
[TBL] [Abstract][Full Text] [Related]
15. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
[TBL] [Abstract][Full Text] [Related]
17. Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Lu FB; Zheng KI; Rios RS; Targher G; Byrne CD; Zheng MH
J Gastroenterol Hepatol; 2020 Dec; 35(12):2041-2050. PubMed ID: 32573017
[TBL] [Abstract][Full Text] [Related]
18. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
[TBL] [Abstract][Full Text] [Related]
20. Nonobese Fatty Liver Disease.
Kim D; Kim WR
Clin Gastroenterol Hepatol; 2017 Apr; 15(4):474-485. PubMed ID: 27581063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
